Book a demo

Cut patent&paper research from weeks to hours with PatSnap Eureka AI!

Try now
Akoustis & Cornell v. Qorvo – GaN Semiconductor Patent Dispute | PatSnap
Explore in Eureka
Case ID2:23-cv-00180
FiledApr 2023
ClosedDec 2024
Patent Litigation

Akoustis & Cornell v. Qorvo: GaN Epitaxial Process Patent Dismissed With Prejudice

Akoustis Technologies, Akoustis Inc., Cornell University, and Cornell Research Foundation jointly sued Qorvo over US7250360B2 — a Cornell-originated patent covering epitaxial AlN, AlGaN, and GaN semiconductor growth processes — targeting Qorvo’s QPD1000 device. The case ended after 600 days via joint stipulation of dismissal with prejudice, with each party bearing its own costs.

Resolution time
600days
600 days from filing to dismissal — roughly 20 months, typical for E.D. Texas patent cases settling before trial
Patents asserted
1
US7250360B2 — GaN/AlN/AlGaN epitaxial semiconductor layer growth process patent
Outcome
Dismissed with Prejudice
Joint stipulation; all claims and counterclaims dismissed with prejudice, each side bears own costs
Cost ruling
Own Costs
Court ordered each party to bear its own costs, expenses, and attorneys’ fees — no fee-shifting
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

Cornell GaN Process Patent Triggers E.D. Texas Dispute With Qorvo

Filed on 20 April 2023 in the Eastern District of Texas, this infringement action was brought by Akoustis Technologies, Inc., Akoustis, Inc., Cornell University, and Cornell Research Foundation, Inc. against Qorvo, Inc. The central patent-in-suit, US7250360B2, covers a process for growing epitaxial layers of AlN, AlGaN, or GaN on lattice-mismatched substrates — a foundational technique for wide-bandgap semiconductor fabrication. Plaintiffs alleged that Qorvo’s QPD1000 device practiced this patented process.

The case closed on 10 December 2024 via a joint stipulation of dismissal with prejudice — meaning all claims, counterclaims, and affirmative defenses asserted by all parties are permanently extinguished. The Court accepted and acknowledged the stipulation, denying all pending relief as moot. Crucially, neither side was awarded costs, expenses, or attorneys’ fees, a neutral cost allocation that typically accompanies a negotiated resolution rather than a unilateral capitulation.

At 600 days, the case ran a full pre-trial cycle before resolving — suggesting the parties likely engaged in substantial claim construction and discovery before reaching terms. The public record does not disclose any licensing agreement, financial consideration, or technical concession underlying the stipulation. The ‘with prejudice’ designation bars any re-filing of these specific claims, providing Qorvo with finality on the asserted patent while leaving the broader GaN epitaxial IP landscape — including other Akoustis and Cornell-held patents — unresolved.

Case at a glance
Case no.2:23-cv-00180
DefendantQorvo, Inc.
CourtTexas Eastern
JudgeN/A
FiledApril 20, 2023
ClosedDecember 10, 2024
Duration600 days
OutcomeDismissed with Prejudice
Verdict causeInfringement Action
BasisDismissed with Prejudice
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / Texas Eastern District Court via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to Dismissed with Prejudice in 600 days

600 days from filing to dismissal — roughly 20 months, typical for E.D. Texas patent cases settling before trial

Case timeline: Complaint filed APR 20 2023, FEB–MAR — 600 days total Horizontal timeline showing the three key events in Akoustis Technologies, Inc. v Qorvo, Inc. from filing to resolution. Source: PACER, Texas Eastern District Court. APR 20 2023 Complaint filed Pre-trial proceedings DEC 10 2024 Dismissed with Prejudice 600 DAYS TOTAL
Dismissal terms

Dismissed with prejudice: what the joint stipulation means for both parties

Legal mechanism

Dismissal with prejudice bars re-filing on these claims

A dismissal with prejudice under Fed. R. Civ. P. 41 is a final adjudication on the merits for res judicata purposes. The specific claims asserted in this case — infringement of US7250360B2 by the QPD1000 and the related process — cannot be re-litigated between these parties. The joint nature of the stipulation signals a negotiated endpoint rather than a unilateral withdrawal, though the precise terms remain confidential.

Permanent bar on re-filing
Patent holder outcome

Akoustis and Cornell lose litigation leverage on this patent

With prejudice dismissal means Akoustis Technologies, Akoustis Inc., Cornell University, and Cornell Research Foundation cannot assert US7250360B2 against Qorvo on the QPD1000 again. The patent itself remains in force and may still be asserted against other defendants, but the dismissal removes it as an enforcement tool specifically against Qorvo for the conduct at issue. No cost award suggests the outcome was commercially negotiated.

Patent survives; Qorvo-specific bar
Defendant outcome

Qorvo secures permanent resolution of this infringement action

Qorvo obtains a with-prejudice dismissal covering all claims and its own counterclaims and affirmative defenses — providing clean finality. The mutual dismissal of counterclaims suggests Qorvo may have had invalidity or non-infringement defenses in play. Each side bearing its own costs is consistent with a settlement structure in which neither party conceded liability. Qorvo’s QPD1000 product is no longer subject to this specific litigation threat.

Full finality; no liability finding
Commercial implications

GaN epitaxial process IP remains a live risk for the sector

US7250360B2 covers a pre-treatment process step critical to GaN-on-silicon and GaN-on-SiC device fabrication — a method broadly relevant to RF power amplifiers, 5G front-end modules, and defence electronics. The with-prejudice dismissal resolves the Qorvo dispute but does not invalidate the patent. Other GaN device manufacturers operating similar epitaxial growth processes should assess their exposure to this Cornell-originated IP and related portfolio continuations.

Broader GaN sector risk persists
Legal analysis based on PACER docket records for case 2:23-cv-00180 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffAkoustis Technologies, Inc.CompanySemiconductor IP commercialisation and university technology transfer — holder of US7250360B2Search in Eureka ↗
Co-PlaintiffCornell UniversityIndividualSearch in Eureka ↗
Co-PlaintiffCornell Research Foundation, Inc.CompanySearch in Eureka ↗
Co-PlaintiffAkoustis, Inc.CompanySearch in Eureka ↗
DefendantQorvo, Inc.CompanyQorvo, Inc. — global RF semiconductor manufacturer, maker of the accused QPD1000 deviceSearch in Eureka ↗
Plaintiff counselCaroline Elyse BurksAttorneyCounsel for Akoustis Technologies, Inc.Search in Eureka ↗
Plaintiff counselGeorge Theodore Fishback , Jr.AttorneyCounsel for Akoustis Technologies, Inc.Search in Eureka ↗
Plaintiff counselJames E QuigleyAttorneyCounsel for Akoustis Technologies, Inc.Search in Eureka ↗
Plaintiff counselJennifer Leigh TrueloveAttorneyCounsel for Akoustis Technologies, Inc.Search in Eureka ↗
Plaintiff counselJohn Bruce Campbell , Jr.AttorneyCounsel for Akoustis Technologies, Inc.Search in Eureka ↗
Plaintiff counselKyle N. RymanAttorneyCounsel for Akoustis Technologies, Inc.Search in Eureka ↗
Plaintiff counselSamuel Franklin BaxterAttorneyCounsel for Akoustis Technologies, Inc.Search in Eureka ↗
Plaintiff law firmMcKool Smith PCLaw FirmRepresenting Akoustis Technologies, Inc.Search in Eureka ↗
Plaintiff law firmMcKool Smith PC (Marshall)Law FirmRepresenting Akoustis Technologies, Inc.Search in Eureka ↗
Plaintiff law firmMcKool Smith PC (Austin)Law FirmRepresenting Akoustis Technologies, Inc.Search in Eureka ↗
Defendant counselDarren Matthew FranklinAttorneyCounsel for Qorvo, Inc.Search in Eureka ↗
Defendant counselJennifer Klein AyersAttorneyCounsel for Qorvo, Inc.Search in Eureka ↗
Defendant counselJonathan R DeFosseAttorneyCounsel for Qorvo, Inc.Search in Eureka ↗
Defendant counselKazim NaqviAttorneyCounsel for Qorvo, Inc.Search in Eureka ↗
Defendant counselMark Thomas RatwayAttorneyCounsel for Qorvo, Inc.Search in Eureka ↗
Defendant counselRobert M. MastersAttorneyCounsel for Qorvo, Inc.Search in Eureka ↗
Defendant counselRoy JungAttorneyCounsel for Qorvo, Inc.Search in Eureka ↗
Defendant counselTimothy P CremenAttorneyCounsel for Qorvo, Inc.Search in Eureka ↗
Defendant counselZachary AlperAttorneyCounsel for Qorvo, Inc.Search in Eureka ↗
Defendant law firmSheppard Mullin Richter & Hampton LLP – DCLaw FirmRepresenting Qorvo, Inc.Search in Eureka ↗
Defendant law firmSheppard Mullin Richter & Hampton LLP (Dallas)Law FirmRepresenting Qorvo, Inc.Search in Eureka ↗
Defendant law firmSheppard Mullin Richter & Hampton, LLPLaw FirmRepresenting Qorvo, Inc.Search in Eureka ↗
Presiding judgeJudge N/AJudgeTexas Eastern District CourtSearch in Eureka ↗
Official verdict

Official order — verbatim text

“Before the Court is the Joint Stipulation of Dismissal With Prejudice (the "Stipulation") filed by Plaintiffs AKOUSTIS TECHNOLOGIES, INC., AKOUSTIS, INC., CORNELL UNIVERSITY, and CORNELL RESEARCH FOUNDATION, INC ("Plaintiffs") and Defendant QORVO, INC. ("Defendant" and with Plaintiffs, the "Parties"). (Dkt. No. 156.) In the Stipulation, the Parties agree "that all claims, counterclaims, and affirmative defenses asserted by Akoustis Technologies, Inc., Akoustis, Inc., Cornell University, Cornell Research Foundation, Inc., and Qorvo, Inc. are to be dismissed WITH PREJUDICE." (Id. at 1.) Having considered the Stipulation, the Court ACCEPTS AND ACKNOWLEDGES that all claims and causes of action asserted between Plaintiffs and Defendant in the abovecaptioned case are DISMISSED WITH PREJUDICE. Each party is to bear its own costs, expenses, and attorneys’ fees. All pending requests for relief in the above-captioned case not explicitly granted herein are DENIED AS MOOT”
Source: PACER Docket, Case 2:23-cv-00180, Texas Eastern District Court

The Court’s order closely tracks the joint stipulation language, accepting and acknowledging — rather than independently adjudicating — the dismissal. This phrasing confirms the outcome is entirely consent-driven: the Court made no finding on infringement, validity, or damages. The mutual dismissal of counterclaims and affirmative defenses, combined with the symmetric cost allocation, is consistent with a confidential settlement in which neither party made a public concession. US7250360B2 emerges from this litigation with its validity untested and enforceable against third parties.

PACER case 2:23-cv-00180 · Public docket record Explore in Eureka ↗
Patent at issue

US7250360B2 — Epitaxial GaN/AlN/AlGaN growth process on mismatched substrates

Publication No.US7250360B2
Application No.US11/069040
Patent details
ProductEpitaxial GaN/AlN/AlGaN layer growth process on lattice-mismatched substrates via Group III pre-treatment
Cited in actionApril 20, 2023

US7250360B2, originating from Cornell University (application number US11/069040), protects a semiconductor fabrication process in which epitaxial layers of aluminium nitride (AlN), aluminium gallium nitride (AlGaN), or gallium nitride (GaN) are grown on lattice-mismatched substrates. The distinguishing claim element is a pre-treatment step: the substrate surface is exposed to at least one Group III reactant — or Group II reactant — at an elevated growth temperature before any Group V or Group VI reactant is introduced. This nucleation approach is designed to improve crystal quality and reduce defect density in wide-bandgap semiconductor devices.

GaN-on-SiC and GaN-on-Si processes governed by this type of nucleation sequence are foundational to modern RF power amplifiers, 5G base-station front-end modules, and high-electron-mobility transistors (HEMTs). Cornell’s patent, commercialised through Akoustis, represents a strategic upstream IP position: any manufacturer using MOCVD or similar techniques with a Group III pre-treatment step on a mismatched substrate could fall within the claim scope. The patent’s enforceability against Qorvo was never tested on the merits, leaving its commercial threat to the broader RF semiconductor ecosystem intact.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should you run an FTO against US7250360B2 for your GaN epitaxial process?

Any R&D team or product group developing GaN-on-SiC, GaN-on-Si, or AlGaN/GaN HEMT devices using MOCVD or HVPE growth should assess their fabrication process against US7250360B2. The critical claim question is whether your epitaxial growth sequence involves pre-treating the substrate with a Group III species — such as trimethylgallium or trimethylaluminium — at elevated temperature before introducing nitrogen or another Group V precursor. This sequence is common in commercial MOCVD nucleation layers and may map onto the patent’s independent claims.

PatSnap Eureka’s FTO Search Agent can map your specific process parameters against the claim language of US7250360B2 and surface related Cornell and Akoustis continuation patents that may carry forward similar claim scope. Eureka’s semantic claim analysis identifies process step overlaps that keyword searches miss, and its portfolio monitoring alerts you to new prosecution activity from Cornell Research Foundation — giving your legal and engineering teams the lead time to design around or challenge claims before litigation risk materialises.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US7250360B2 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar GaN semiconductor process patent cases in E.D. Texas

Cases involving GaN epitaxial process patents and wide-bandgap semiconductor infringement disputes filed in the Eastern District of Texas, including RF device and HEMT-related actions.

🔍
Access 40+ similar cases in PatSnap Eureka
Akoustis Technologies, Inc. patent enforcement history, Texas Eastern case history, Akoustis Technologies, Inc.’s full IP portfolio, and comparable case analysis
Other GaN patent actionsCornell IP enforcement historyAkoustis v. other defendantsE.D. Texas semiconductor cases
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the GaN semiconductor IP landscape

The Akoustis-Cornell v. Qorvo dismissal highlights how university-commercialised process patents remain potent enforcement tools in the RF semiconductor space.

University-originated process patents are increasingly monetised via litigation

Cornell Research Foundation’s co-plaintiff role demonstrates the growing trend of research universities actively enforcing foundational semiconductor process patents through commercial partners. Companies operating GaN epitaxial growth lines should audit their fabrication processes against Cornell’s patent portfolio, particularly pre-treatment steps involving Group III reactants at elevated temperatures.

E.D. Texas remains a preferred venue for semiconductor process patent disputes

Plaintiffs chose the Eastern District of Texas — a historically plaintiff-friendly venue with efficient scheduling. For defendants like Qorvo, this creates early pressure to engage. The 600-day duration to a with-prejudice dismissal suggests the parties used the full pre-trial window, including likely Markman proceedings, before reaching commercial terms. Monitor this court for related Akoustis or Cornell filings.

🔒
Full strategic analysis in PatSnap Eureka
Unlock deeper analysis of GaN semiconductor IP strategy, MOCVD process claim scope, and Qorvo’s E.D. Texas defence posture.
Qorvo invalidity strategyCornell GaN portfolio mapMOCVD process claim scope
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

Akoustis v Qorvo — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Monitor GaN semiconductor process patent risk with PatSnap Eureka

US7250360B2 emerged from this case with its validity untested and its claims intact. Run an FTO on your GaN epitaxial fabrication process and track Cornell and Akoustis continuation filings before the next enforcement action is filed.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Related Litigation Cases

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.